ES511317A0 - Procedimiento para preparar derivados de imidazol. - Google Patents

Procedimiento para preparar derivados de imidazol.

Info

Publication number
ES511317A0
ES511317A0 ES511317A ES511317A ES511317A0 ES 511317 A0 ES511317 A0 ES 511317A0 ES 511317 A ES511317 A ES 511317A ES 511317 A ES511317 A ES 511317A ES 511317 A0 ES511317 A0 ES 511317A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
imidazol derivatives
imidazol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511317A
Other languages
English (en)
Other versions
ES8304091A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES8304091A1 publication Critical patent/ES8304091A1/es
Publication of ES511317A0 publication Critical patent/ES511317A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES511317A 1981-04-13 1982-04-08 Procedimiento para preparar derivados de imidazol. Granted ES511317A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8111614 1981-04-13

Publications (2)

Publication Number Publication Date
ES8304091A1 ES8304091A1 (es) 1983-02-16
ES511317A0 true ES511317A0 (es) 1983-02-16

Family

ID=10521121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511317A Granted ES511317A0 (es) 1981-04-13 1982-04-08 Procedimiento para preparar derivados de imidazol.

Country Status (12)

Country Link
US (2) US4567189A (es)
EP (1) EP0062918B1 (es)
JP (1) JPS57179165A (es)
CA (1) CA1174680A (es)
DE (1) DE3272262D1 (es)
DK (1) DK162882A (es)
ES (1) ES511317A0 (es)
IE (1) IE52702B1 (es)
NO (1) NO157736C (es)
NZ (1) NZ200300A (es)
PT (1) PT74736B (es)
ZA (1) ZA822478B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3369984D1 (en) * 1982-07-12 1987-04-09 Searle & Co 1-(1h-imidazolyl), 1-n-morpholinyl and pyridyl compounds, their preparation and pharmaceutical compositions containing them
FR2557875B1 (fr) * 1984-01-11 1986-04-25 Jouveinal Sa Aminoethylimidazole, composition pharmaceutique en contenant et procede de preparation
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
US5214063A (en) * 1990-06-27 1993-05-25 Adir Et Compagnie 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036970A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. Imidazol-1-yl propane derivatives
DE2720949A1 (de) * 1977-05-10 1978-11-23 Bayer Ag Azolylaether-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
US4215220A (en) * 1978-09-11 1980-07-29 Cilag-Chemie A.G. 1-(2-Oxysubstituted-3-anilinopropyl)-imidazoles
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf

Also Published As

Publication number Publication date
US4636518A (en) 1987-01-13
NO157736B (no) 1988-02-01
JPS57179165A (en) 1982-11-04
IE820868L (en) 1982-10-13
CA1174680A (en) 1984-09-18
ES8304091A1 (es) 1983-02-16
JPH0368864B2 (es) 1991-10-30
NO821206L (no) 1982-10-14
IE52702B1 (en) 1988-01-20
NO157736C (no) 1988-05-11
EP0062918B1 (en) 1986-07-30
PT74736B (en) 1983-11-09
PT74736A (en) 1982-05-01
DE3272262D1 (en) 1986-09-04
EP0062918A3 (en) 1983-09-28
ZA822478B (en) 1983-02-23
DK162882A (da) 1982-10-14
NZ200300A (en) 1985-05-31
EP0062918A2 (en) 1982-10-20
US4567189A (en) 1986-01-28

Similar Documents

Publication Publication Date Title
ES514016A0 (es) Procedimiento para preparar derivados de n-fenilpirazol.
ES507715A0 (es) Procedimiento para preparar derivados de 1-sulfo-2-oxoazetidina .
ES516588A0 (es) Procedimiento para preparar derivados de piridona.
ES517332A0 (es) Procedimiento para preparar derivados de feniltiadiazinona.
ES514796A0 (es) Procedimiento para preparar compuestos tetrakisazoicos.
ES523733A0 (es) Procedimiento para preparar acilanilidas.
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
ES512295A0 (es) Procedimiento para preparar derivados de piridina.
ES516717A0 (es) Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio.
ES519402A0 (es) Procedimiento para preparar derivados de guanidina.
ES510258A0 (es) Procedimiento para preparar derivados de quanadina.
ES508803A0 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES517333A0 (es) Procedimientos para preparar derivados piridazinona.
ES509044A0 (es) Procedimiento para preparar derivados de fenilsulfonilurea sustituidos.
ES527945A0 (es) Procedimiento para preparar derivados de bencilcarbamoilpiridina.
ES511317A0 (es) Procedimiento para preparar derivados de imidazol.
ES537959A0 (es) Procedimiento para preparar derivados de imidazol.
ES509436A0 (es) Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos.
ES511911A0 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES509734A0 (es) Procedimiento para preparar derivados de benzotiadiazol-amina.
ES525333A0 (es) Procedimiento para preparar derivados de sulfamoilbenzofenona.
ES509825A0 (es) Procedimiento para preparar derivados de la ergolina.
ES510584A0 (es) Procedimiento para preparar derivados de guanidina.
ES509744A0 (es) Procedimiento para preparar derivados sustituidos de tetrahidropirimidinona.
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".